Literature DB >> 29619603

Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats.

Poonam Ruhal1, Dinesh Dhingra2.   

Abstract

In the present study, the effect of inosine was evaluated on learning and memory of 18 months old aged female rats. Inosine (50, 100 and 200 mg/kg; i.p.) was administered to separate groups of rats for 15 successive days. Donepezil (1 mg/kg; i.p.), an acetylcholinesterase inhibitor, was used as a standard drug. Behavioral models such as Morris water maze and elevated plus maze were used to evaluate the effect of drugs on learning and memory of rats. After behavioral studies, animals were killed and their brain was isolated and further processed for estimation of various biochemical parameters such as acetylcholinesterase activity, oxidative stress markers, proinflammatory marker and histological examinations. Inosine (100 and 200 mg/kg) significantly improved learning and memory of aged rats. Further, inosine significantly reduced lipid peroxidation and nitrite, and increased the levels of reduced glutathione and superoxide dismutase. However, no significant difference in AChEs activity was observed in inosine-treated rats as compared to aged control rats. TNF-α level was found to be ameliorated in aged rats by inosine. Histopathological evaluation showed that inosine-treated aged rats have less number of pyknotic neurons in hippocampal CA1 region as compared to aged control rats. In conclusion, inosine significantly improved learning and memory of aged female rats possibly through its antioxidant as well as anti-inflammatory effect and improvement of neuronal survival in the hippocampal CA1 region. However, additional studies are required to further explore the downstream signaling pathways involved in the neuroprotective effect of inosine in aged animals.

Entities:  

Keywords:  Aging; Dementia; Inosine; Learning; Memory

Mesh:

Substances:

Year:  2018        PMID: 29619603     DOI: 10.1007/s10787-018-0476-y

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  56 in total

Review 1.  Immunomodulatory and neuroprotective effects of inosine.

Authors:  György Haskó; Michail V Sitkovsky; Csaba Szabó
Journal:  Trends Pharmacol Sci       Date:  2004-03       Impact factor: 14.819

2.  Protective effects of inosine on mice subjected to lethal total-body ionizing irradiation.

Authors:  Bing Hou; Zhi-Wei Xu; Chao-Wen Yang; Yan Gao; Shi-Fu Zhao; Cheng-Gang Zhang
Journal:  J Radiat Res       Date:  2006-12-19       Impact factor: 2.724

3.  Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems.

Authors:  K Fukui; K Onodera; T Shinkai; S Suzuki; S Urano
Journal:  Ann N Y Acad Sci       Date:  2001-04       Impact factor: 5.691

4.  Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.

Authors:  Swapnil Sonkusare; Krishnamoorthy Srinivasan; Chamanlal Kaul; Poduri Ramarao
Journal:  Life Sci       Date:  2005-05-20       Impact factor: 5.037

5.  Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats.

Authors:  R B Gibbs
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

6.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 7.  Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA.

Authors:  Zsolt Radak; Zhongfu Zhao; Sataro Goto; Erika Koltai
Journal:  Mol Aspects Med       Date:  2011-10-15

8.  Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury-induced cytokine response after excitotoxic damage.

Authors:  O Campuzano; M M Castillo-Ruiz; L Acarin; B Castellano; B Gonzalez
Journal:  J Neurosci Res       Date:  2009-08-15       Impact factor: 4.164

9.  Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction.

Authors:  Anil Kumar; Jitendriya Mishra; Kanwaljit Chopra; Dinesh K Dhull
Journal:  Psychopharmacology (Berl)       Date:  2015-10-08       Impact factor: 4.530

10.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more
  12 in total

1.  Investigating the Effect of Inosine on Brain Purinergic Receptors and Neurotrophic and Neuroinflammatory Parameters in an Experimental Model of Alzheimer's Disease.

Authors:  Fernanda Cardoso Teixeira; Mayara Sandrielly Pereira Soares; Eduardo Bierhaus Blödorn; William Borges Domingues; Karine Paula Reichert; Adriana Maria Zago; Fabiano Barbosa Carvalho; Jessie Martins Gutierres; Relber Aguiar Gonçales; Marilda da Cruz Fernandes; Vinicius Farias Campos; Maria Rosa Chitolina; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Mol Neurobiol       Date:  2021-11-18       Impact factor: 5.590

2.  Protective Effects of Inosine on Memory Consolidation in a Rat Model of Scopolamine-Induced Cognitive Impairment: Involvement of Cholinergic Signaling, Redox Status, and Ion Pump Activities.

Authors:  Fernanda Cardoso Teixeira; Bruna da Silveira de Mattos; Julia Eisenhardt de Mello; Juliane Cardoso; Luiza Spohr; Karina Pereira Luduvico; Mayara Sandrielly Pereira Soares; Fabiano Barbosa Carvalho; Jessie Martins Gutierres; Anelize de Oliveira Campello Felix; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Neurochem Res       Date:  2021-10-08       Impact factor: 3.996

3.  The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine receptors.

Authors:  Pedro Valada; Sonja Hinz; Christin Vielmuth; Cátia R Lopes; Rodrigo A Cunha; Christa E Müller; João Pedro Lopes
Journal:  Purinergic Signal       Date:  2022-09-26       Impact factor: 3.950

Review 4.  Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction.

Authors:  Lori A Birder; Edwin K Jackson
Journal:  Nat Rev Urol       Date:  2022-09-07       Impact factor: 16.430

5.  Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial.

Authors:  Mohammad Mahdi Shahpouri; Majid Barekatain; Mahgol Tavakoli; Shervin Badihian; Vahid Shaygannejad
Journal:  Int J Prev Med       Date:  2020-06-19

6.  Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

7.  Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.

Authors:  Kenneth Maiese
Journal:  Int Rev Neurobiol       Date:  2020-08-11       Impact factor: 3.230

Review 8.  Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.

Authors:  Kenneth Maiese
Journal:  Expert Rev Clin Pharmacol       Date:  2020-01-03       Impact factor: 5.045

9.  Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: a nucleoside with multitarget brain actions.

Authors:  Fernanda Cardoso Teixeira; Jessié Martins Gutierres; Mayara Sandrielly Pereira Soares; Bruna da Siveira de Mattos; Luiza Spohr; Carlus Augustu Tavares do Couto; Natália Pontes Bona; Charles Elias Assmann; Vera Maria Morsch; Ivana Beatrice Mânica da Cruz; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Psychopharmacology (Berl)       Date:  2019-12-13       Impact factor: 4.530

10.  Impacting dementia and cognitive loss with innovative strategies: mechanistic target of rapamycin, clock genes, circular non-coding ribonucleic acids, and Rho/Rock.

Authors:  Kenneth Maiese
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.